The Estrobolome: Why Her Estrogen Keeps Coming Back

You can support every phase of estrogen detoxification correctly and still watch the levels climb back, because the last step does not happen in the liver. It happens in the gut, and whether it finishes depends on the bacteria living there.

Where estrogen actually goes

Most practitioners can recite the first two phases. The failure point is after them.

Phase I hydroxylates estrogen into its metabolites — 2-OH, 4-OH and 16-OH — via cytochrome P450. Which pathway dominates matters, and 4-OH is the one that can form reactive intermediates if it is not handled promptly.

Phase II neutralises those metabolites and prepares them for removal: methylation of the catechol estrogens through COMT, plus glucuronidation and sulfation. The product is a conjugated estrogen — water-soluble, tagged for disposal, no longer active.

Phase III is excretion. Some leaves via the kidneys. A large share is packaged into bile and sent into the intestine.

And this is where the textbook usually stops, as though arriving in the gut were the same thing as leaving the body.

It isn't. Conjugated estrogen in the intestine still has to make it out, and in the hours it spends travelling it is exposed to the microbiome. Whatever happens in that window decides whether the liver's work holds — or is simply undone and sent back.

The enzyme that undoes it

Certain gut bacteria produce beta-glucuronidase, and what it does is precise: it cleaves the glucuronide tag the liver attached.

That tag was the entire point of Phase II. It is what made the estrogen water-soluble, inactive and ready to leave. Remove it and the estrogen is free, active and lipophilic again — sitting in the intestine in exactly the form that gets reabsorbed through the intestinal wall and returned to circulation.

This is enterohepatic recirculation. The liver conjugates, the bile delivers, the bacteria deconjugate, the gut reabsorbs, and the liver has to do the work a second time.

The collection of gut organisms capable of this is what people mean by the estrobolome — the part of the microbiome that metabolises estrogen.

The implication is the part worth sitting with. A patient's circulating estrogen load is not set only by how much she makes and how well her liver processes it. It is also set by how much of what she already excreted gets sent back. Two women with identical ovarian output and identical liver function can carry very different estrogen burdens because of what lives in their colon.

What raises it

Four things, and none of them are hormonal.

Dysbiosis. Beta-glucuronidase production is a bacterial trait. Shift the composition of the microbiome and you shift how much of the enzyme is being made. This is the direct link between a gut finding and a hormone result.

Constipation. Transit time is exposure time. The longer conjugated estrogen sits in the intestine, the more opportunity there is for deconjugation and reabsorption. A woman with estrogen symptoms who opens her bowels twice a week has a hormone problem that is partly a motility problem.

Low fibre. Fibre binds conjugated estrogen and carries it out. Without it, more remains available for the enzyme to act on — which is most of why the fibre advice in hormone care is real rather than generic.

Low bile flow. Phase III depends on bile to deliver conjugated estrogen to the intestine in the first place. Sluggish bile means the handoff is poor before the microbiome is even involved.

Read that list again and notice what is on it: the microbiome, transit, diet and bile. Every one of them is a gut variable. None of them appear anywhere on a hormone panel.

Why the protocol keeps failing

Picture the case, because you have almost certainly had it.

A woman with heavy periods, breast tenderness, fibroids, premenstrual rage. Estrogen-dominant picture, clear as day. You support Phase I, you push methylation for Phase II, you add the usual estrogen-clearance agents. She improves — genuinely, for a while.

Then it drifts back. You tighten the protocol. It drifts back again.

What is happening is that you are treating production and conjugation in a patient whose problem is reabsorption. The liver is doing its job and the gut is reversing it. You can run that loop for a year.

The tell is in her bowel history, which is why it is worth asking about in a hormone consultation: constipation alongside estrogen symptoms is not a coincidence, it is a mechanism. So is a history of antibiotics. So is a diet with almost no fibre in it.

And this cuts the other way too — which is the more hopeful half. Clear the dysbiosis, restore transit, get fibre in, and estrogen symptoms sometimes resolve without a single hormone-directed intervention. The patient will tell you her hormones are better. What actually changed was her colon.

What to measure

The answer sits across two tests, which is exactly why this gets missed — the gut practitioner does not order the hormone panel and the hormone practitioner does not order the stool test.

Question	Where to look
Is she deconjugating and reabsorbing?	Beta-glucuronidase on the GI Map
Which Phase I pathway dominates?	2-OH, 4-OH and 16-OH metabolites on a DUTCH
Is Phase II methylation keeping up?	Methylated metabolites on a DUTCH
Is dysbiosis driving the enzyme?	The organism sections of the GI Map
Is transit part of it?	Her bowel history. No test required

The last row is free and it is the one most likely to change your plan.

And read the two reports together rather than in sequence. An elevated beta-glucuronidase means something quite different in a woman whose DUTCH shows an unfavourable Phase I pattern than it does in one whose metabolism looks clean — in the first she is recirculating metabolites you particularly did not want recirculating.

The order to work in

1. Ask about bowels before you order anything. Frequency, form, effort. In a woman with estrogen symptoms this is a hormone question.

2. Fix transit first. Nothing downstream works while conjugated estrogen is sitting in the colon for three days.

3. Get fibre in. It is the mechanism, not a wellness aside — it binds conjugated estrogen and removes it.

4. Address the dysbiosis. Beta-glucuronidase is produced by organisms. Change the organisms and you change the enzyme.

5. Support bile flow, so Phase III delivers properly in the first place.

6. Then work on Phase I and II — which is where most protocols start, and where they should arrive.

If you take one thing from this: in a patient with estrogen symptoms and a sluggish gut, the gut comes first. Not because hormones do not matter, but because the hormone work will not hold while the exit is blocked.

This one sits across two of the guides. The Gut Guide covers GI Map interpretation marker by marker, beta-glucuronidase included, with protocols for the dysbiosis underneath it. The Hormone Guide covers DUTCH interpretation and Phase I, II and III hormone detoxification with condition-specific protocols and dosing. Both are in the complete library.